Exelixis | EXEL - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
Acadia Pharmaceuticals 10.08 1.53 2026-03
Agios Pharmaceuticals 3.56 0 2026-03
Akebia Therapeutics 1.63K 1.6K 2025-12
Amgen 19.84 5.47 2026-03
AstraZeneca 29.59 2.3 2026-03
Bayer 3.4 8.75 2026-03
BioMarin Pharmaceutical 15.28 3.96 2026-03
Bristol-Myers Squibb 9.08 0.2 2026-03
Eisai 35.61 8.98 2026-03
Eli Lilly 40.27 0.06 2026-03
Esperion Therapeutics 129.79 129 2024-12
Exelixis 13.91 588.4 2026-03
Genmab 17.14 4.39 2025-12
Glaxosmithkline 11.66 0.28 2025-12
Incyte 15.35 0.51 2026-03
Ionis Pharmaceuticals 396.15 79.28 2022-09
Merck 16.52 2.6 2026-03
Moderna 27.22 14.51 2023-06
Neurocrine Biosciences 28.09 807.38 2026-03
Novartis 20.17 2.32 2026-03
Pfizer 9.32 5.16 2026-03
Puma Biotechnology 13.93 44.88 2024-06
Sanofi 15.75 1.53 2025-12
Takeda 46.52 188.53 2026-03
Xencor 29.92 3.22 2022-09